Infection and Immunology
IMS researchers investigate infectious diseases and immune system function across scales — from the dynamics of pathogen transmission to the cellular and molecular basis of chronic infection. This work advances prevention, diagnosis, and treatment of infectious diseases, immune-mediated conditions, and autoimmune disorders.
Our scientists are at the forefront of addressing emerging and persistent global health threats, including antibiotic-resistant bacteria and viruses such as COVID-19, HIV, Ebola, and mpox. Through innovative, translational research, they contribute to improved public health outcomes locally, nationally, and globally.
Search our faculty directory for experts in this field.
Student Research
Highlights
The results of two clinical trials show that Paxlovid, an oral antiviral drug, does not reduce hospital admissions or deaths in vaccinated adults at higher risk of severe COVID-19. However, the drug does help people recover a few days faster.
Episode #89 - Vaccines: Making History
The emergence of mRNA vaccines has allowed for the fastest development of a vaccine in history and could be a sign of what's to come in the future.
A team of clinicians and researchers at UofT, UHN and Unity Health Toronto have reported the first Canadian case of sustained HIV remission — and possible cure — in a 62-year-old man who received a bone marrow transplant to treat cancer.
Less than three months since it launched, the mpox rapid research response led by UofT’s Emerging and Pandemic Infections Consortium and three partner hospitals is generating results that could help curb transmission of the virus.